Inicio>>Signaling Pathways>> GPCR/G protein>> Adrenergic Receptor>>Dapiprazole hydrochloride

Dapiprazole hydrochloride

Catalog No.GC30188

El clorhidrato de dapiprazol es un antagonista de los receptores adrenérgicos alfa-1 potente, selectivo y activo por vÍa oral.

Products are for research use only. Not for human use. We do not sell to patients.

Dapiprazole hydrochloride Chemical Structure

Cas No.: 72822-13-0

Tamaño Precio Disponibilidad Cantidad
10mM (in 1mL DMSO)
31,00 $
Disponible
5mg
28,00 $
Disponible
10mg
45,00 $
Disponible
25mg
89,00 $
Disponible
50mg
136,00 $
Disponible
100mg
203,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Dapiprazole hydrochloride is a potent α-adrenergic blocking drug, which is used to reverse mydriasis after eye examination.(1) It inhibits amphetamine toxicity and alcohol and morphine withdrawal syndromes, produces sedation, blocks conditioned avoidance reflexes and reduces the response to noxious stimuli.(2) The orally administrated daily dose varied from 30 to 90 mg.

[1]. Ramesh T et al.Development and validation of a stability-indicating RP-HPLC assay method and stress degradation studies ondapiprazole. J Chromatogr Sci. 2013 Oct;51(9):856-60. [2]. Marx-Gross S et al. Brimonidine versus dapiprazole: Influence on pupil size at various illumination levels. J Cataract Refract Surg. 2005 Jul;31(7):1372-6.

Reseñas

Review for Dapiprazole hydrochloride

Average Rating: 5 ★★★★★ (Based on Reviews and 22 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Dapiprazole hydrochloride

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.